Abstract
Since 2012, use of daily preventive medication, such as pre-exposure prophylactic (PrEP) therapy, has been recommended as an effective HIV prevention strategy. However, rates of PrEP use remain low, and disparities exist between populations at highest risk of HIV infection and those who take PrEP. Primary care nurse practitioners should routinely screen patients for risk of HIV acquisition and interest in PrEP and provide PrEP to patients who desire to use it. This report summarizes PrEP guidelines, common barriers to use of PrEP, strategies to overcome barriers to PrEP use, and recommendations to implement PrEP in primary care practices.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
